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Abstract
Background: To secure pH homeostasis, the central respiratory network must permanently adapt its rhythmic motor drive
to environment and behaviour. In neonates, it is commonly admitted that the retrotrapezoid/parafacial respiratory group of
neurons of the ventral medulla plays the primary role in the respiratory response to acidosis, although the serotonergic
system may also contribute to this response.
Methodology/Principal Findings: Using en bloc medullary preparations from neonatal mice, we have shown for the first
time that the respiratory response to acidosis is abolished after pre-treatment with the serotonin-transporter blocker
fluoxetine (25–50 mM, 20 min), a commonly used antidepressant. Using mRNA in situ hybridization and immunohistology,
we have also shown the expression of the serotonin transporter mRNA and serotonin-containing neurons in the vicinity of
the RTN/pFRG of neonatal mice.
Conclusions: These results reveal that the serotonergic system plays a pivotal role in pH homeostasis. Although obtained in
vitro in neonatal mice, they suggest that drugs targeting the serotonergic system should be used with caution in infants,
pregnant women and breastfeeding mothers.
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Introduction
From birth onwards, the neonatal mammal must be able to
breathe and adapt its breathing activity to environmental changes
and behaviors. Therefore a correct function of the ponto-
medullary respiratory network is required at birth, not only for
the elaboration of the respiratory rhythm but also for its
adaptation to physiological needs. In neonates, the respiratory
rhythm generator (RRG) is composed of two coupled, interacting
networks: the preBo¨tzinger complex (preBo¨tC) which contains the
primary rhythm generating neurons in brainstem slices [1,2] and
the parafacial respiratory group (pFRG). The pFRG neurons
express the transcription factor Phox2b, display a pre-inspiratory
discharge and play a major role in detecting CO2/pH changes
and adjusting the RRG activity in neonatal and juvenile animals
[3,4]. In embryos, organized rhythmic activities emerge in the
preBo¨tC and pFRG as early as at embryonic day 15.5 and 14.5,
respectively [5–7]. After birth, the embryonic pFRG forms the
retrotrapezoid nucleus (RTN) with Phox2b glutamatergic neurons
detecting changes in CO2/pH, receiving peripheral inputs from
carotid bodies chemoreceptors, and controlling the respiratory
network [8–10]. The RTN/pFRG neurons are severely depleted
in transgenic mouse model of the Central Congenital Hypoven-
tilation Syndrome, a rare disease defined by the lack of CO2/pH
responsiveness and RRG automaticity during sleep [11].
Although the RTN/pFRG neurons have a crucial role in
ventilatory responses to CO2/pH changes in neonates, the serotonin
(5-HT) neurons also contribute to the maintenance of blood gas
homeostasis [12–14]. As recently reviewed, the 5-HT neurons are
involved in respiratory function and dysfunction [14], they
synaptically contact the RRG [15], modulate the activity of the
maturing RRG [16], are intrinsically chemosensitive in vitro, are
stimulated by hypercapnia in vivo, and their disruption alters the
ventilatory response to CO2/pH changes [12,17,18]. In a transgenic
mouse model of Prader-Willi syndrome, a rare disease with complex
symptoms including frequent apnoeas during sleep and blunted
ventilatory responses to CO2/pH, the medullary 5-HT levels are
abnormally increased at birth and the ventilatory responses to CO2/
pH reduced [15]. In addition, an altered 5HT system and insufficient
ventilatory responses to CO2/pH and/or hypoxia during sleep might
contribute to sudden infant death syndrome (SIDS), the main cause
of death in infants in industrialized countries [14,18–21].
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The present work aimed at a further elucidation of the role of
endogenous 5-HT in the RRG response to CO2/pH in neonatal
mice. Using en bloc medullary preparations where the isolated
RRG still functions in vitro and responds to CO2/pH changes, we
show that a pre-treatment with fluoxetine, a blocker of the
serotonin transporter (SERT) and 5-HT re-uptake, abolishes the
RRG responses to CO2/pH. Using mRNA hybridization and
immunohistology, we also report SERT mRNA expression and a
few 5-HT neurons in the vicinity of the RTN/pFRG area. As
fluoxetine is a commonly used antidepressant known to increase
endogenous levels of 5-HT [22], we suggest a cautious use of
pharmacological treatments targeting the 5HT system in infants,
pregnant women and breastfeeding mothers.
Materials and Methods
Ethics Statement
The experiments were performed on neonatal mice (n = 48)
born from C57BL6 mice (Charles River Laboratories; l’Arbresle,
France) housed with food and water ad libitum and were
conducted in agreement with the European Communities Council
Directive (86/609/EEC) (permit number 13–426 to Nicolas
Voituron; approved by Direction De´partementale des Services
Ve´te´rinaires - Pre´fecture des Bouches du Rhoˆne, France).
Surgery and electrophysiology
The medulla and cervical cord of neonatal mice (n = 42;
postnatal days 1–3) were dissected, placed in a 2 ml in vitro
recording chamber and superfused (.2 ml per min) with artificial
cerebro-spinal fluid (aCSF), as reported previously [15]. Under
these conditions, the isolated RRG continued to function,
producing rhythmic bursts on phrenic roots for long periods of
time. The 4th cervical ventral root containing the axons of phrenic
motoneurons was sucked in a glass micropipette. Its electrical
activity was filtered (100–3000 Hz), amplified (65000), integrated
(time constant 100 ms), digitized and stored (1 Khz; Spike 2 data
system; Cambridge Electronic Design, UK).
As reported previously [7,23], two different aCSF, bubbled with
carbogene and maintained at 27uC, were used: a normal aCSF
(pH=7.4) and an acidified aCSF (pH=7.1), and pH values were
regularly measured (pHmeter P107, Consort, Bioblock Scientific).
The composition of the normal aCSF, also termed below
aCSF(7.4), was (in mM): 129.0 NaCl, 3.35 KCl, 21.0 NaHCO3,
1.26 CaCl2, 1.15 MgCl2, 0.58 NaH2PO4, and 30.0 D-glucose.
The composition of the acidified aCSF, also termed below
aCSF(7.1), was similar but NaHCO3 was reduced to 10.0 mM
[7,23]. This protocol already used by us [7] and others [23] to
impose reproducible acidosis to en bloc medullary preparations
without bubbling gases containing higher levels of CO2 and lower
levels of O2 in the superfusate, was used to examine the direct
effects of acidosis on the activity produced by the isolated
respiratory network. In a first set of experiments, the RRG
response to acidosis was analyzed by subjecting preparations to 5
or 10 min application of aCSF(7.1). In a second set of
experiments, the effect of pre-treating the preparations with
aCSF(7.4) containing fluoxetine (10 mM or 50 mM; 20 min) was
investigated on the RRG response to acidosis. Fluoxetine is a well-
known antidepressant of common clinical use that blocks the
serotonin transporter (SERT), the blockade of the 5-HT reuptake
increasing the 5-HT endogenous levels and potentiating the 5-HT
effects at the synaptic cleft [22]. After fluoxetine pre-treatment, the
RRG response to acidosis was investigated by subjecting the
preparations to aCSF(7.1) containing the same amount of
fluoxetine for 5 min. In a third set of experiments, the RRG
response to acidosis was investigated after pre-treatment with
aCSF(7.4) containing 5-HT (1 mM or 5 mM; 20 min) to mimic the
effect of fluoxetine by increasing the extracellular level of 5-HT.
After 5-HT pre-treatment, the RRG response to acidosis was
analyzed by subjecting the preparations to aCSF(7.1) containing
the same amount of 5-HT for 5 min. All drugs were purchased
from Sigma (Sigma-Aldrich, Saint-Quentin Fallavier, France) and
dissolved in aCSF.
For each individual experiment (n = 42), the phrenic burst
frequency (PBf) was measured every min. The 5 min period under
aCSF(7.4) prior to any drug application was used to define the
control PBf (100%) and the changes in PBf induced by application
of the modified aCSF were expressed in % of control PBf.
Standardized experiments were repeated on different preparations
from different litters and only one trial was performed per
preparation. The mean changes in PBf were averaged min after
min from different preparations and the results were given as
mean 6 SEM. As in previous reports [15,16,24,25], the figures
present the mean PBf changes as % of the control PBf, whereas the
statistical analysis of the changes in PBf was performed on absolute
values (cycle per min, c.min21) using a student’s paired t-test to
compare the PBf during acidosis to the mean PBf calculated
during the five min prior to the acidosis tests. The level of
statistical significance was set at p,0.05.
SERT mRNA expression and 5-HT neurons analysis
To analyze SERT mRNA expression in neonatal mice (n = 3),
brains were dissected at postnatal day 6 and frozen in isopentane
at 230uC. Sections (10 mm) were prepared with a cryostat at
220uC, thaw-mounted on glass slides and stored at 280uC until
usage. Regional mRNA hybridization in situ for the SERT
sequences (Mus musculus, accession numbers: NM_010484.2) was
performed as already described [26] with the following antisens
oligonucleotide:
59- GGAGGAGATGAGGTAGTAGAGCGCCCAGGCTA-
TG-39,
59- GAACAGGAGAAACAGAGGGCTGATGGCCACCC-
AG-39,
59-CTCAGCAGGTGACGTGGAATGGAGTGTCCAGG-
TG-39,
59- AGAACCAAGACACGACGACGGCCTCGATGAGA-
GC -39
and 59- CCCACACCCCTGTCTCCAAGAGTTTCTGCCA-
GTTGG-39, using Helios oligo design software (http://www.
heliosbioscience.com, Helios Biosciences, France) [26]. Negative
controls were performed using labeled sense oligonucleotides. In
brief, oligonucleotides were labeled with [35S]-dATP, using
terminal transferase (Amersham Biosciences, UK), to a specific
activity of 56108 dpm/mg. Sections were covered with 100 ml of
an hybridization of Helios medium [26] and 3–56105 dpm of
each labeled oligonucleotide. Samples were incubated overnight at
42uC, washed and exposed to BAS-TR Fuji Imaging screens (Fuji
Film Photo Co., Tokyo, Japan) for 4–5 days. Screens were then
scanned with a Fuji Bioimaging Analyzer BAS-5000 (Fuji Film
Photo Co., Tokyo, Japan).
To analyze 5-HT neurons expression, brainstems were
dissected at postnatal day 3 (n = 3) and fixed in 4% paraformal-
dehyde dissolved in phosphate-buffered saline (PBS; 0.1 M
phosphate buffer at pH 7.4+0.15 M NaCl). Free-floating serial
coronal sections (70 mm thickness; vibroslicer Campden Instru-
ments, Longhborough, UK) were first incubated for 30 min at
room temperature in a blocking solution (BS) containing 1%
normal goat serum and 0.3% w/v Triton X-100 in PBS, followed
by overnight incubation at 4uC in an anti-5HT antibody (Sigma),
Fluoxetine and Acidosis
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diluted 1:1,000 in BS. After rinsing in PBS, the sections were
incubated for 4 hours at room temperature in a goat anti-mouse
IgG Rhodamine-conjugated (Jackson ImmunoResearch, West
Grove, PA), diluted 1:200 in PBS containing 1% normal goat
serum, rinsed again, and incubated overnight at 4uC in a mouse
PAP complex (Sigma), diluted 1:100 in PBS. On the following
day, the sections were first rinsed and pre-treated for 20 min in a
cobalt (0.5%) solution and rinsed; then the PAP complex was
developed with 3, 39-diaminobenzidine (DAB 0.04%) and
hydrogen peroxide (0.01%). After rinsing in cold PBS, the
sections were mounted on gelatin-chromalin coated slides, dried
overnight, stained with neutral red (1% in H2O), dehydrated in a
graded series of ethanol (70%, 80%, 95%, and 100%), cleared in
xylene, coverslipped with DPX, investigated in transmitted light,
and photographed.
Results
The isolated RRG generated rhythmic phrenic bursts with
stable amplitude and frequency (Fig. 1A) and the mean PBf under
aCSF(7.4) containing no drugs (10.060.7 c.min21; n = 42) was
fully consistent with previously reported values [15].
Acidosis increases the PBf of en bloc medullary
preparations
To analyze the PBf changes induced by acidosis, we measured
the control PBf every min in twelve preparations superfused with
aCSF(7.4) for at least 20 min followed by superfusion with
aCSF(7.1) for five min. As shown in Fig. 1B, the mean PBF did
not change in the first two min of acidosis, after which it
significantly increased to reach 13368% of the control PBf during
Figure 1. Acidosis increases the phrenic burst frequency of en bloc medullary preparations. A – Schematic presentation of the en bloc
preparation of neonatal mice (A1) and example of raw and integrated phrenic bursts (bottom and top traces, respectively) produced by the isolated
respiratory rhythm generator (RRG) on the C4 ventral roots of en bloc preparations (A2). B – Columns of the histogram show the mean (and SEM)
phrenic burst frequency (PBf; expressed as % of the control PBf) measured every min (one column =1 min) in 12 en bloc preparations when the
control aCSF(7.4) (white columns) superfusing the preparations was replaced by aCSF(7.1) for 5 min (black columns). Note that acidosis significantly
increased the PBf (asterisks indicate a p,0.05 statistical difference). C- As in B but aCSF(7.1) application for 10 min to 6 other preparations. Note that
the PBf reached a plateau from the 5th to the 10th min of aCSF(7.1) application.
doi:10.1371/journal.pone.0013644.g001
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the last min of acidosis. When superfusion with aCSF(7.4) was
resumed, the PBf recovered control values within two min. In a
second set of experiments, six other preparations were also
subjected to aCSF(7.1) but the application was maintained for ten
min instead of five min to know whether longer period of acidosis
induced more marked changes in the PBf (Fig. 1C). The PBf did
not significantly change in the first min of acidosis, slightly but
significantly increased at the 2nd min, reached 142610% at the 5th
min and thereafter remained at a plateau until the 10th min of
acidosis (132613% of control) when superfusion with aCSF(7.4)
was resumed, the PBf returning to control values.
Neither five nor ten min of acidosis significantly affected the
mean amplitude of the integrated PB (data not shown). As five and
ten min of acidosis similarly increased the PBf, data corresponding
to the PBf changes induced by the first five min of acidosis in the
two types of experiments (five and ten min of acidosis) were pooled
together. On the whole sample of 18 preparations, acidosis always
increased the PBf. It had no significant effects on the mean PBf
during the first min, weakly but significantly increased it from the
second min (11264%) and raised the PBf up to 13766% of the
control at the 5th min. No significant relationship was found
between the PBf increment induced by acidosis at the 5th min and
the control PBf prior to acidosis (r = 0.312; df = 16; p.0.1). In
addition, no significant difference was observed between the mean
PBf increment induced by acidosis at the 5th min in preparations
displaying the highest (13.160.6 c.min21, n = 5) vs. the lowest
(5.960.2 c.min21, n = 5) control PBf (mean PBf increment:
3.761.4 c.min21 and 2.360.7 c.min21, respectively; P.0.2).
Therefore, acidosis increased the PBf in all the preparations, even
when the control PBf was high. Because the five-min application of
acidified aCSF was more likely to reflect the physiological
breathing responses to transient blood acidosis than the ten-min
application, we only tested below the PBf changes induced by five
min of acidosis.
Excess of 5HT abolishes the PBf response to acidosis
In a second set of experiments, preparations were subjected to
pre-treatment with aCSF containing fluoxetine, a well-known
SERT blocker known to increase 5-HT endogenous levels [22],
prior to investigating the PBf responses to acidosis. As applications
of fluoxetine at large concentration (100 mM) were reported to
double the mean PBf [16], we used weaker concentrations to avoid
marked increases of the resting PBf. Indeed, pre-treatments with
fluoxetine at 10 mM (n= 6) and 50 mM (n=4) did not significantly
affect the resting PBf at either concentrations and therefore data
were pooled (n= 10). As shown in Fig. 2A, subjecting the
preparations to aCSF(7.4) containing fluoxetine for 20 min did
not significantly increase the mean PBf during the last five min of
Figure 2. Fluoxetine and serotonin pre-treatments abolish the increase of phrenic burst frequency induced by acidosis. A - Columns
of the histogram show the mean (and SEM) PBf (expressed as % of the control PBf) measured every min (one column =1 min) in 10 preparations
when the control aCSF(7.4) (white columns) superfusing the preparations was first replaced by aCSF(7.4) containing fluoxetine (10–25 mM) for 20 min
to block the serotonin transporter SERT (grey columns) and thereafter by aCSF(7.1) containing the same amount of fluoxetine for 5 min (black
columns). Note that pre-treatment with fluoxetine did not significantly increase the PBf but abolished the PBf increase under acidosis. B - PBf changes
(expressed as % of control) every min (one column) but for 14 preparations superfused with control aCSF(7.4) (white columns), aCSF(7.4) containing
serotonin, 5-HT (1–5 mM) for 20 min (grey columns) and thereafter aCSF(7.1) containing the same amount of 5-HT for 5 min (black columns). Note
that pre-treatment with 5-HT significantly increased the PBf by about 50% and, similarly to fluoxetine treatment, abolished the PBf increase under
acidosis.
doi:10.1371/journal.pone.0013644.g002
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fluoxetine (11366% of the control; p.0.1). Then, to investigate
the effect of fluoxetine pre-treatment on the PBf response to
acidosis, the aCSF(7.4) containing fluoxetine was replaced by
aCSF(7.1) containing the same amount of fluoxetine for 5 min.
Acidosis slightly but non-significantly decreased the PBf, the PBf
being similar to control at the 5th min. Thus, pre-treating en bloc
medullary preparations with the SERT blocker fluoxetine
abolished the PBf response to acidosis.
To mimic the fluoxetine-induced increase of 5-HT levels,
fourteen other preparations were subjected to aCSF(7.4) containing
weak concentrations of exogenous 5-HT for 20 min. Two different
concentrations of 5-HT were used, 1 mM (n=7) and 5 mM (n=7).
After 20 min of application, they both slowly and significantly
increased the PBf by around 50% and similarly altered the PBf
response to acidosis; therefore data were pooled (n= 14). As shown
in Figure 2B, aCSF(7.4) containing 5-HT slowly and significantly
increased the PBf up to a plateau at 15166% of the control during
the five last min of 5-HT pre-treatment. Thereafter, applying
aCSF(7.1) containing the same amount of 5-HT for 5 min to 14
preparations either reduced the PBf (8367% of control; n = 6) or
increased it (130610% of control; n = 8). On the whole sample
(n= 14), acidosis after 5-HT pre-treatment did not significantly
affect the PBf at the 5th min (11269% of control; p.0.1). No
significant relationship was found between the PBf responses to
acidosis and the control PBf either prior to (r =20.174; df = 12;
p.0.1) or after 5-HT pre-treatment (r =20.346; df = 12; p.0.1).
In addition, no significant difference was observed between the PBf
response to acidosis in preparations displaying the highest
(22.762.4 c.min21; n = 5) vs. the lowest (12.260.7 c.min21;
n = 6) PBf under 5-HT (mean PBf response: 0.260.9 c.min21 and
1.461.6 c.min21, respectively; P.0.2).Then, exposure of prepara-
tions to exogenous 5-HT abolished the PBf response to acidosis,
even when the PBf was moderately increased by 5-HT exposure.
SERT mRNA expression and 5-HT neurons in the RTN/
pFRG area
To decipher the mechanisms through which the SERT blocker
fluoxetine abolished the PBf response to acidosis, we examined
possible fluoxetine targets with in situ hybridization for SERT
mRNA in 10 mm medullary sections of three neonatal mice. We
identified the brainstem section level from observation of adjacent
sections stained with Cresyl Violet. As previously [7], we defined
the RTN/pFRG area as located below the caudal part of the facial
motor nucleus (n7), rostral to the appearance of the nucleus
ambiguous. SERT mRNA was constantly found expressed in three
distinct ventral spots of medullary sections cut at the RTN/pFRG
level (Fig. 3A). First, SERT mRNA expression formed a median,
large and heavily stained triangle, possibly delimiting the raphe
magnus (Rm in Fig. 3). Second, SERT mRNA expression was also
found at a more lateral spot, about 500 mm from the midline, just
lateral to the pyramidal tract (py), in an area possibly
corresponding to the para-pyramidal subgroup of 5-HT neurons
(ppy in Fig. 3). Third, a distinct and small spot of SERT mRNA
was observed 200–300 mm laterals from the ppy, ventral to the
medial part of the facial nucleus (n7). This small lateral spot was
observed in the three studied neonatal mice (arrows in Fig. 3).
The SERT mRNA spot in the vicinity of the RTN/pFRG of
neonatal mice was consistent with the dense 5-HT innervation to
the RTN/pFRG described in rats [27–29]. However, as SERT
mRNA expression could only originate from 5-HT somata and
not 5-HT terminals, we used antibody against 5-HT to seek for 5-
HT-containing neurons in sections passing at the RTN/pFRG
level. We clearly identified three distinct groups of 5-HT neurons
(Fig. 3B1) forming the medial raphe magnus, the lateral ppy
column and a lateral group of a few scattered 5-HT neurons. The
latter 5-HT-containing neurons were located very close to the
ventral surface and medial to the n7 (Fig. 3B2, B3) and were highly
likely at the origin of the most lateral SERT mRNA spot found in
the vicinity of the RTN/pFRG area.
Asides from the RTN/pFRG area, our in situ hybridization
studies revealed a very dense expression of SERT mRNA in all the
median raphe nuclei and all along the ppy column of 5-HT
neurons. At the caudal medullary level, SERT mRNA expression
was also found in the respiratory-related areas of the ventro-lateral
medulla, below the nucleus ambiguous, but not in the dorsal
medulla (data not shown).
Discussion
In neonatal mice, we report that the PBf response to acidosis is
abolished by pre-treatment with the SERT blocker fluoxetine and
that SERT mRNA and 5-HT neurons are found in the vicinity of
the RTN/pFRG area. These new results are of main importance
since they argue for a pivotal role of the 5-HT system in the PBf
response to acidosis and suggest that altered 5-HT metabolism in
infants may affect the breathing response to acidosis.
Basic aspects of the PBf responses to acidosis
In medullary preparations of neonatal mice, acidosis increases
the PBf by about 40% without affecting the phrenic burst
amplitude, in agreement with previous reports in neonatal rats
[30] and foetal mice [7]. Compelling evidence exist that the
neonatal RTN/pFRG plays a main role in the PBf response to
acidosis [3,4,8–10]. However, the one min latency of the PBf
response appears to be long since the RTN/pFRG chemorecep-
tors are close to the ventral surface and rapidly detect CO2/pH
changes [28]. The RRG responds in a few seconds when the
RTN/pFRG neurons are stimulated by direct photo-activation in
vivo [31] or direct CO2/pH stimulation in vitro [32]. The kinetics of
the PBf responses to acidified aCSF applications have not been
previously documented in details but latencies in a min range are
commonly illustrated [30,33,34]. Aside the superficial RTN/
pFRG chemoreceptors, several groups of chemoreceptors are
described in discrete brainstem areas, such as the pontine
catecholaminergic A5 and A6 areas, the ventrolateral medulla
and the raphe areas [33,35]. Indeed, the 5-HT neurons play a
crucial role in respiratory function and dysfunction [14]: they are
intrinsically chemosensitive [12], synaptically contact the respira-
tory neurons [15] and exert a facilitatory modulation on the RRG
via a release of endogenous 5HT and activation of 5-HT1A
receptors [16,36]. Although some 5-HT neurons are very close to
the ventral surface of the medulla, most are located deeper in the
brainstem than the superficial RTN/pFRG chemoreceptors and
may require a longer latency to detect acidosis. As five and ten min
acidosis applications similarly affect the PBf, we speculate that the
PBf response to acidosis we have analyzed reflects the integrated
response of the whole medullary chemosensitive system rather
than the solely response of superficial RTN/pFRG chemorecep-
tors.
Basic aspects of the fluoxetine abolition of the PBf
response to acidosis
Fluoxetine blocks SERT and increases the 5-HT endogenous
level and the 5-HT availability at the synaptic cleft [22,37].
Correlatively, fluoxetine potentiates the facilitation of the RRG by
endogenous 5-HT, doubling the resting PBf when applied at
100 mM [16]. Herein applying fluoxetine at weaker concentrations
did not significantly increase the PBf but totally abolished the PBf
Fluoxetine and Acidosis
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response to acidosis. Mimicking the fluoxetine-induced increase in
5-HT levels with exogenous 5-HT application significantly
increased the PBf and also totally abolished the PBf response.
The abolition of the PBf response by 5-HT applications was
unlikely caused by the increased resting PBf since no significant
relationship was found between the resting PBf and the magnitude
of the PBf response to acidosis under normal aCSF as well as
under aCSF containing 5-HT.
Our histological results in neonatal mice show SERT mRNA
expression in all areas known to contain 5-HT neurons as well as
in the vicinity of the RTN/pFRG area where we also report 5-
HT-containing neurons. In the RTN/pFRG of neonatal rats,
SERT immunoreactivity and 5-HT receptors expression has been
reported, such a dense 5-HT innervation forming a possible
anatomical substrate for 5HT-dependent control of RTN/pFRG
chemoreceptors [27–29]. In neonatal mice, the neurons expressing
the SERT mRNA and containing 5-HT in the vicinity of the
RTN/pFRG area may be viewed as a lateral subcluster of 5-HT
neurons from the ppy column but it cannot be excluded that they
are not actual 5-HT neurons. During development, SERT
expression can transiently occur in some glutamatergic non-5-
HT neurons allowing them to take up and store 5-HT released
from neighbouring terminals [38]. Further experiments are
required to examine whether the SERT-expressing and 5-HT-
containing neurons in the vicinity of the RTN/pFRG area are
actual 5-HT neurons able to synthesize 5-HT or glutamatergic
RTN/pFRG neurons expressing SERT and up-taking 5-HT.
Nevertheless, fluoxetine blockade of 5-HT uptake may affect the
5-HT levels, the pH response of brainstem chemoreceptors and
the RRG activity and responsiveness. Application of 5-HT to
RTN/pFRG chemoreceptors increases their baseline level but not
the magnitude of their response to pH [28]. Thus, the abolition of
the PBf responses to acidosis by fluoxetine cannot be simply
explained by a decreased chemosensitivity of RTN/pFRG
neurons and it possibly reflects more complex, 5-HT dependent
mechanisms affecting the whole chemosensitive system.
Within the maturing CNS, endogenous 5-HT acts through a
plethora of receptors subtypes to modulate maturational processes,
synaptic mechanisms and neuronal excitability [14,38]. Similarly
5-HT exerts multiple effects on the neonatal respiratory network,
facilitating the RRG via 5-HT1A receptors, depolarizing and
firing the phrenic motoneurons via 5-HT2A receptors and
reducing the transmission of the respiratory drive to motoneurons
via 5-HT1B receptors [14,16,24,25,36,39]. An excess of endog-
Figure 3. SERT mRNA and 5-HT-containing neurons in the vicinity of the RTN/pFRG of neonatal mice. A: Two serial coronal sections
passing through the RTN/PFRG area of a neonatal mouse show SERT mRNA expression (A1) and Cresyl Violet staining (A2). Anatomical limits drawn
from A2 Cresyl Violet section have been superimposed on A1 section (dotted line). Note SERT mRNA is expressed in three areas, the median Raphe
Magnus (Rm), the para-pyramidal group (ppy) lateral to the pyramid tract (py) and a lateral spot (arrow) located in a medio-ventral position from the
facial motor nucleus (n7), as defined from Cresyl Violet staining (in A2). B- 5-HT neurons in the RTN/pFRG area of a neonatal mouse. Note 5-HT
neurons in the median raphe magnus (Rm), the parapyramidal group (ppy, doted circle) lateral to the pyramidal tract (py) and the lateral spot (arrow
in B1) in the medio-ventral location of the facial nucleus (n7). In B2 and B3, note the superficial location of some 5-HT neurons (arrows). B3 is an
enlargement of B1.
doi:10.1371/journal.pone.0013644.g003
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enous 5-HT affects the expression of 5-HT1A receptors, the RRG
modulation by 5-HT [36,40] and may also affect non-5HT
systems known to modulate the RRG such as the catecholamin-
ergic system [41,42]. In addition, 5-HT may affect the gap
junction coupling. Gap junction coupling occurs between cultured
chemoreceptors [43] as well as between chemoreceptors of discrete
brainstem areas such as the locus coeruleus [44], the raphe [45]
and the RTN/pFRG [46]. Frequent gap junctions contribute to
the synchronous firing of raphe neurons [45] and may lead the
brainstem chemoreceptors to behave as a syncytium [47].
Blockade of gap junctions reduces the in vivo RTN/pFRG
chemosensitivity [48] and the in vitro resting PBf [49]. Interestingly,
the gap junction coupling is reduced by excess of 5-HT [50,51].
We therefore speculate that the fluoxetine-induced excess of 5-HT
reduces the gap junction coupling between brainstem chemore-
ceptors and that a disorganized chemoreceptor drive to the RRG
during acidosis may affect the PBf response.
Thus, the fluoxetine-induced excess of 5-HT may directly (via
the 5-HT system) and indirectly (via other neurotransmitter
systems) affect the RRG responsiveness to acidosis as well as the
elaboration of the chemoreceptor drive. Although further
experiments are required to decipher these different, non-exclusive
mechanisms, data from several lines of transgenic mice further
support a link between 5-HT and RRG response to CO2/pH.
Indeed, genetically-induced alterations of the 5-HT system in mice
affect the RRG responses to CO2/pH, as reported in SERT
knockout mice [37,52] and lmx1b and Pet-1 knockout mice
[53,54]. In mouse model for Prader-Willi syndrome, a rare disease
with blunted breathing responses to CO2/pH, neonates have
excess of 5-HT in the medulla and reduced breathing response to
CO2/pH [15]. In mouse model for the Central Congenital
Hypoventilation Syndrome, the respiratory responses to pH are
abolished, the number of 5-HT neurons is normal but nothing has
been reported about 5-HT metabolism yet [11].
Translational aspects of 5-HT and breathing responses to
acidosis in infants
SIDS, the main cause of infant death in industrialized countries,
might result from developmental abnormality of the 5-HT system
leading to altered breathing responses to CO2/pH during sleep
[18–21]. Alterations of 5-HT metabolism, number of 5-HT
neurons, SERT expression and 5-HT receptors expression have
been reported in SIDS and a subset of SIDS infants has genetic
polymorphisms impacting the 5-HT system [14,18–20]. Although
our results have been obtained in vitro and in neonatal mice, they
may be of some values for infants. Indeed, they are fully consistent
with 5-HT metabolism anomalies altering breathing response to
CO2/pH and increasing SIDS risks.
SERT is the primary target for widely used antidepressants.
Depression concerns up to 2–3% of the pregnant women
population and mothers are often subjected to treatment with
SERT inhibitors, which may indirectly affect the foetuses via
placental transfer and the infants via breastfeeding, resulting to
clinical manifestations in 30% of the neonates, including breathing
symptoms [55]. As it cannot be excluded that fluoxetine treatment
of the mother depresses the infant breathing response to CO2/pH,
we suggest that antidepressants targeting the 5-HT system are used
with caution during pregnancy and breastfeeding period, with
careful follow-up of infants exposed to these agents.
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